Therapy monitoring in congenital adrenal hyperplasia by dried blood samples

Journal of Pediatric Endocrinology & Metabolism : JPEM
Isabelle WieackerKlaus Mohnike

Abstract

Careful monitoring of the therapy is crucial for patients with congenital adrenal hyperplasia (CAH) in order to prevent the effects of increased androgen production as well as life-threatening salt-wasting crisis. The key metabolite, 17α-hydroxyprogesterone (17-OHP) can be detected in serum, saliva or dried blood. In clinical practice there are challenges due to discomfort of venous blood sampling and complicated retrieval of saliva during infancy. Furthermore, the immunoassay method is limited in its specificity due to cross-reactions. In this observational study we prospectively examined over a period of 5 years, 20 patients with CAH due to 21-hydroxylase deficiency using standard immunoassays for serum samples (radioimmunoassay and enzyme immunoassay) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) in dried blood spots. Bland-Altman plots show goodness of agreement between both the methods for the desirable therapeutic concentration range of 17-OHP. LC-MS/MS is characterized by a high accuracy in the therapeutic concentration range of 17-OHP <100 nmol/L (r=0.91). Dried blood samples are convenient and reliable specimen for 17-OHP measured by LC-MS/MS. This method could be used for home monitoring of hydrocortis...Continue Reading

References

Jun 1, 1988·Archives of Disease in Childhood·M C YoungI A Hughes
Jan 1, 1984·Annual Review of Medicine·M I New, L S Levine
Aug 22, 2003·The New England Journal of Medicine·Phyllis W Speiser, Perrin C White
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Carla Z MinuttiDietrich Matern
Mar 8, 2008·The Journal of Clinical Endocrinology and Metabolism·Deborah P Merke
Jun 6, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Eftihios TrakakisDemetrios Kassanos
Jun 9, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Peter C Hindmarsh
Jul 3, 2009·Pediatrics in Review·Zoltan Antal, Ping Zhou
Jul 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Walter BonfigHans Peter Schwarz
Nov 26, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Claudia RossiMichael Morris
Dec 29, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Manfred Rauh
Jun 19, 2010·Clinical Chemistry·Andrew DauberJoseph A Majzoub

❮ Previous
Next ❯

Citations

Dec 16, 2016·Journal of Pediatric Endocrinology & Metabolism : JPEM·Niels H BirkebaekArieh S Cohen
May 8, 2021·Endocrine Reviews·Hedi L Claahsen-van der GrintenPerrin C White

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.